Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Respiratory Tract Diseases × AZD3759 × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Meningeal Carcinomatosis 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Respiratory Tract Diseases 1 Neoplasms 1 Lung Neoplasms 1

Interventions

selpercatinib 2 alectinib 1 Pemetrexed 1 Gefitinib 1 Erlotinib Hydrochloride 1 Carboplatin 1 AZD3759 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03653546 2025-09-10

BM

Alpha Biopharma (Jiangsu) Co., Ltd.

Phase 2/3 Completed

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Respiratory Tract Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡